Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study
Background:
While patterns of incidence of clinical influenza have been well described, much uncertainty remains over patterns of incidence of infection. The 2009 pandemic provided both the motivation and opportunity to investigate patterns of mild and asymptomatic infection using serological techniques. However, to date, only broad epidemiological patterns have been defined, based on largely cross-sectional study designs with convenience sampling frameworks.
Methods and Findings:
We conducted a paired serological survey of a cohort of households in Hong Kong, recruited using random digit dialing, and gathered data on severe confirmed cases from the public hospital system (>90% inpatient days). Paired sera were obtained from 770 individuals, aged 3 to 103, along with detailed individual-level and household-level risk factors for infection. Also, we extrapolated beyond the period of our study using time series of severe cases and we simulated alternate study designs using epidemiological parameters obtained from our data. Rates of infection during the period of our study decreased substantially with age: for 3–19 years, the attack rate was 39% (31%–49%); 20–39 years, 8.9% (5.3%–14.7%); 40–59 years, 5.3% (3.5%–8.0%); and 60 years or older, 0.77% (0.18%–4.2%). We estimated parameters for a parsimonious model of infection in which a linear age term and the presence of a child in the household were used to predict the log odds of infection. Patterns of symptom reporting suggested that children experienced symptoms more often than adults. The overall rate of confirmed pandemic (H1N1) 2009 influenza (H1N1pdm) deaths was 7.6 (6.2–9.5) per 100,000 infections. However, there was substantial and progressive increase in deaths per 100,000 infections with increasing age from 0.66 (0.65–0.86) for 3–19 years up to 220 (50–4,000) for 60 years and older. Extrapolating beyond the period of our study using rates of severe disease, we estimated that 56% (43%–69%) of 3–19 year olds and 16% (13%–18%) of people overall were infected by the pandemic strain up to the end of January 2010. Using simulation, we found that, during 2009, larger cohorts with shorter follow-up times could have rapidly provided similar data to those presented here.
Conclusions:
Should H1N1pdm evolve to be more infectious in older adults, average rates of severe disease per infection could be higher in future waves: measuring such changes in severity requires studies similar to that described here. The benefit of effective vaccination against H1N1pdm infection is likely to be substantial for older individuals. Revised pandemic influenza preparedness plans should include prospective serological cohort studies. Many individuals, of all ages, remained susceptible to H1N1pdm after the main 2009 wave in Hong Kong.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study. PLoS Med 8(6): e32767. doi:10.1371/journal.pmed.1000442
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000442
Souhrn
Background:
While patterns of incidence of clinical influenza have been well described, much uncertainty remains over patterns of incidence of infection. The 2009 pandemic provided both the motivation and opportunity to investigate patterns of mild and asymptomatic infection using serological techniques. However, to date, only broad epidemiological patterns have been defined, based on largely cross-sectional study designs with convenience sampling frameworks.
Methods and Findings:
We conducted a paired serological survey of a cohort of households in Hong Kong, recruited using random digit dialing, and gathered data on severe confirmed cases from the public hospital system (>90% inpatient days). Paired sera were obtained from 770 individuals, aged 3 to 103, along with detailed individual-level and household-level risk factors for infection. Also, we extrapolated beyond the period of our study using time series of severe cases and we simulated alternate study designs using epidemiological parameters obtained from our data. Rates of infection during the period of our study decreased substantially with age: for 3–19 years, the attack rate was 39% (31%–49%); 20–39 years, 8.9% (5.3%–14.7%); 40–59 years, 5.3% (3.5%–8.0%); and 60 years or older, 0.77% (0.18%–4.2%). We estimated parameters for a parsimonious model of infection in which a linear age term and the presence of a child in the household were used to predict the log odds of infection. Patterns of symptom reporting suggested that children experienced symptoms more often than adults. The overall rate of confirmed pandemic (H1N1) 2009 influenza (H1N1pdm) deaths was 7.6 (6.2–9.5) per 100,000 infections. However, there was substantial and progressive increase in deaths per 100,000 infections with increasing age from 0.66 (0.65–0.86) for 3–19 years up to 220 (50–4,000) for 60 years and older. Extrapolating beyond the period of our study using rates of severe disease, we estimated that 56% (43%–69%) of 3–19 year olds and 16% (13%–18%) of people overall were infected by the pandemic strain up to the end of January 2010. Using simulation, we found that, during 2009, larger cohorts with shorter follow-up times could have rapidly provided similar data to those presented here.
Conclusions:
Should H1N1pdm evolve to be more infectious in older adults, average rates of severe disease per infection could be higher in future waves: measuring such changes in severity requires studies similar to that described here. The benefit of effective vaccination against H1N1pdm infection is likely to be substantial for older individuals. Revised pandemic influenza preparedness plans should include prospective serological cohort studies. Many individuals, of all ages, remained susceptible to H1N1pdm after the main 2009 wave in Hong Kong.
: Please see later in the article for the Editors' Summary
Zdroje
1. ThompsonWW
ShayDK
WeintraubE
BrammerL
BridgesCB
2004 Influenza-associated hospitalizations in the United States. JAMA 292 1333 1340
2. ShindeV
BridgesC
UyekiT
ShuB
BalishA
2009 Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360 2616 2625
3. Van KerkhoveMD
AsikainenT
BeckerNG
BjorgeS
Desenclos J-C, et al. 2010 Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med 7 e1000275 doi:10.1371/journal.pmed.1000275
4. DowseGK
SmithDW
KellyH
BarrI
LaurieKL
2011 Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study. Med J Aust 194 68 72
5. GilbertGL
CretikosMA
HuestonL
DoukasG
O'TooleB
2010 Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 5 e12562 doi:10.1371/journal.pone.0012562
6. GrillsN
PiersLS
BarrI
VaughanLM
LesterR
2010 A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health 34 228 231
7. McvernonJ
LaurieK
NolanT
OwenR
IrvingD
2010 Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill 15
8. TsaiTF
PedottiP
HilbertA
LindertK
HohenbokenM
2010 Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009. Euro Surveill 15
9. DengY
PangXH
YangP
ShiWX
TianLL
2011 Serological survey of 2009 H1N1 influenza in residents of Beijing, China. Epidemiol Infect 139 52 58
10. MillerE
HoschlerK
HardelidP
StanfordE
AndrewsN
2010 Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375 1100 1108
11. TandaleBV
PawarSD
GuravYK
ChadhaMS
KoratkarSS
2010 Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 10 255
12. BandaranayakeD
HuangQS
BissieloA
WoodT
MackerethG
2010 Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5 e13211 doi:10.1371/journal.pone.0013211
13. AdamsonWE
MaddiS
RobertsonC
McDonaghS
MolyneauxPJ
2010 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 15
14. ChenMIC
LeeVJM
Lim W-Y, BarrIG
LinRTP
2010 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303 1383 1391
15. PrachayangprechaS
MakkochJ
PayungpornS
ChieochansinT
VuthitanachotC
2010 Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr 28 537 544
16. ZimmerSM
CrevarCJ
CarterDM
StarkJH
GilesBM
2010 Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 5 e11601 doi:10.1371/journal.pone.0011601
17. WuJT
MaESK
LeeCK
ChuDKW
Ho P-L, et al. 2010 The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51 1184 1191
18. MontoAS
KioumehrF
1975 The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. Am J Epidemiol 102 553 563
19. FoxJP
CooneyMK
HallCE
FoyHM
1982 Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 116 228 242
20. CowlingBJ
NgDMW
IpDKM
LiaoQ
LamWWT
2010 Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis 202 867 876
21. CowlingBJ
ChanKH
FangVJ
LauLLH
SoHC
2010 Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 362 2175 2184
22. LeungGM
WongIOL
Chan W-S, ChoiS
Lo S-V, et al. 2005 The ecology of health care in Hong Kong. Soc Sci Med 61 577 590
23. MossongJ
HensN
JitM
BeutelsP
AuranenK
2008 Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5 e74 doi:10.1371/journal.pmed.0050074
24. KaoTM
HsiehSM
KungHC
LeeYC
HuangKC
2010 Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine 28 6159 6163
25. LeeVJ
YapJ
TayJK
BarrI
GaoQ
2010 Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. BMC Infect Dis 10 164
26. RossT
ZimmerS
BurkeD
CrevarC
CarterD
2010 Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza RRN1148
27. RileyS
FergusonNM
2006 Smallpox transmission and control: spatial dynamics in Great Britain. Proc Natl Acad Sci U S A 103 12637 12642
28. FergusonNM
CummingsDAT
CauchemezS
FraserC
RileyS
2005 Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437 209 214
29. YangY
SugimotoJ
HalloranM
BastaN
ChaoD
2009 The transmissibility and control of pandemic influenza A (H1N1) virus. Science
30. InvestigatorsAI
WebbSAR
PettiläV
SeppeltI
BellomoR
2009 Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361 1925 1934
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 6
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Mapping the Risk of Anaemia in Preschool-Age Children: The Contribution of Malnutrition, Malaria, and Helminth Infections in West Africa
- More and Better Information to Tackle HIV Epidemics: Towards Improved HIV Incidence Assays
- Migration and "Low-Skilled" Workers in Destination Countries
- Energy Density, Portion Size, and Eating Occasions: Contributions to Increased Energy Intake in the United States, 1977–2006